Desmopressin Use in Major Cardiac Surgery is Associated with Renal Impairment: a Retrospective Single-center Analysis

Overview

Journal BMC Anesthesiol

Publisher Biomed Central

Specialty Anesthesiology

Date 2024 Oct 7

PMID 39375596

Authors

Andreas Kokofer

Niklas Rodemund

Crispiana Cozowicz

Ottokar Stundner

Lukas Fischer

Bernhard Wernly

Affiliations

Soon will be listed here.

Abstract

Background: Desmopressin acetate (1-deamino-8-d-arginine vasopressin-DDAVP) is a analogue of the antidiuretic hormone vasopressin. DDAVP is suggested to reduce bleeding after cardiac surgery using cardiopulmonary bypass. The aim of this study was to determine if DDAVP has any negative impact on renal function leading to acute kidney injury (AKI) and therefore increases the need for renal replacement therapy (RRT).

Methods: We performed a retrospective single institutional cohort analysis of 2,179 patients undergoing elective and urgent cardiac surgery with CPB from 2017 to 2021. Logistic regression analysis was used to investigate any association between DDAVP, the incidence of AKI KDIGO class 3 and the need for RRT, respectively. The model was adjusted for relevant covariates, including preexisting renal impairment, pharmacological hemodynamic support with vasopressors, complexity of the surgery and postoperative lactate. Secondary outcomes included, in hospital mortality and the need for allogenic blood transfusion.

Results: A total of 992 (45.5%) patients received DDAVP intraoperatively during surgery or shortly thereafter. The use of DDAVP was associated with a significant increase in in AKI KDIGO class 3 (OR 2.27; 95% CI 1.46-3.55; p < 0,001) and the need for RRT (OR 2.19; 95%CI 1.48-3.24; p < 0,001). Both findings persisted after covariate adjusting. No increased in-hospital mortality was associated with DDAVP.

Conclusion: In cardiac surgery, the use of DDAVP was associated with an increased rate of server AKI and the requirement for RRT. Given the severity of the potential harm associated with DDAVP, an evidence-based reevaluation is needed to enable an accurate risk and benefit assessment.

References

Nashef S, Roques F, Sharples L, Nilsson J, Smith C, Goldstone A . EuroSCORE II. Eur J Cardiothorac Surg. 2012; 41(4):734-44. DOI: 10.1093/ejcts/ezs043. View

Srivastava A, Brewer A, Mauser-Bunschoten E, Key N, Kitchen S, Llinas A . Guidelines for the management of hemophilia. Haemophilia. 2012; 19(1):e1-47. DOI: 10.1111/j.1365-2516.2012.02909.x. View

Yousuf M, Samad K, Ahmed S, Siddiqui K, Ullah H . Cardiac Surgery and Blood-Saving Techniques: An Update. Cureus. 2022; 14(1):e21222. PMC: 8844256. DOI: 10.7759/cureus.21222. View

Lassnigg A, Schmidlin D, Mouhieddine M, Bachmann L, Druml W, Bauer P . Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: a prospective cohort study. J Am Soc Nephrol. 2004; 15(6):1597-605. DOI: 10.1097/01.asn.0000130340.93930.dd. View

Despotis G, Levine V, Saleem R, Spitznagel E, Joist J . Use of point-of-care test in identification of patients who can benefit from desmopressin during cardiac surgery: a randomised controlled trial. Lancet. 1999; 354(9173):106-10. DOI: 10.1016/S0140-6736(98)12494-7. View

Nielsen S, Frokiaer J, Marples D, Kwon T, Agre P, Knepper M . Aquaporins in the kidney: from molecules to medicine. Physiol Rev. 2002; 82(1):205-44. DOI: 10.1152/physrev.00024.2001. View

Ferraris V, Brown J, Despotis G, Hammon J, Reece T, Saha S . 2011 update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists blood conservation clinical practice guidelines. Ann Thorac Surg. 2011; 91(3):944-82. DOI: 10.1016/j.athoracsur.2010.11.078. View

Nielsen S, Digiovanni S, Christensen E, Knepper M, Harris H . Cellular and subcellular immunolocalization of vasopressin-regulated water channel in rat kidney. Proc Natl Acad Sci U S A. 1993; 90(24):11663-7. PMC: 48044. DOI: 10.1073/pnas.90.24.11663. View

Levi M, Cromheecke M, de Jonge E, Prins M, de Mol B, Briet E . Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints. Lancet. 2000; 354(9194):1940-7. DOI: 10.1016/S0140-6736(99)01264-7. View

10.

Mehta R, Kellum J, Shah S, Molitoris B, Ronco C, Warnock D . Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007; 11(2):R31. PMC: 2206446. DOI: 10.1186/cc5713. View

11.

Lethagen S, Nilsson I . DDAVP-induced enhancement of platelet retention: its dependence on platelet-von Willebrand factor and the platelet receptor GP IIb/IIIa. Eur J Haematol. 1992; 49(1):7-13. DOI: 10.1111/j.1600-0609.1992.tb00906.x. View

12.

Bellomo R, Ronco C, Kellum J, Mehta R, Palevsky P . Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2004; 8(4):R204-12. PMC: 522841. DOI: 10.1186/cc2872. View

13.

Ozgonenel B, Rajpurkar M, Lusher J . How do you treat bleeding disorders with desmopressin?. Postgrad Med J. 2007; 83(977):159-63. PMC: 2599976. DOI: 10.1136/pgmj.2006.052118. View

14.

Metnitz P, Moreno R, Almeida E, Jordan B, Bauer P, Abizanda Campos R . SAPS 3--From evaluation of the patient to evaluation of the intensive care unit. Part 1: Objectives, methods and cohort description. Intensive Care Med. 2005; 31(10):1336-44. PMC: 1315314. DOI: 10.1007/s00134-005-2762-6. View

15.

Bayman E, Dexter F . Multicollinearity in Logistic Regression Models. Anesth Analg. 2021; 133(2):362-365. DOI: 10.1213/ANE.0000000000005593. View

16.

Vives M, Hernandez A, Parramon F, Estanyol N, Pardina B, Munoz A . Acute kidney injury after cardiac surgery: prevalence, impact and management challenges. Int J Nephrol Renovasc Dis. 2019; 12:153-166. PMC: 6612286. DOI: 10.2147/IJNRD.S167477. View

17.

Pickering J, James M, Palmer S . Acute kidney injury and prognosis after cardiopulmonary bypass: a meta-analysis of cohort studies. Am J Kidney Dis. 2014; 65(2):283-93. DOI: 10.1053/j.ajkd.2014.09.008. View

18.

Furay E, Daley M, Satarasinghe P, Lara S, Aydelotte J, Teixeira P . Desmopressin is a transfusion sparing option to reverse platelet dysfunction in patients with severe traumatic brain injury. J Trauma Acute Care Surg. 2019; 88(1):80-86. DOI: 10.1097/TA.0000000000002521. View

19.

Harrois A, Anstey J . Diabetes Insipidus and Syndrome of Inappropriate Antidiuretic Hormone in Critically Ill Patients. Crit Care Clin. 2019; 35(2):187-200. DOI: 10.1016/j.ccc.2018.11.001. View

20.

Benchimol E, Smeeth L, Guttmann A, Harron K, Moher D, Petersen I . The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) statement. PLoS Med. 2015; 12(10):e1001885. PMC: 4595218. DOI: 10.1371/journal.pmed.1001885. View